129 related articles for article (PubMed ID: 11910753)
21. [Inhibition of hepatitis C virus by antisense oligodeoxynucleotide in vitro].
Liu Y; Chen Z; He N
Zhonghua Yi Xue Za Zhi; 1997 Aug; 77(8):567-70. PubMed ID: 9772458
[TBL] [Abstract][Full Text] [Related]
22. Transferrin-modified liposomes equipped with a pH-sensitive fusogenic peptide: an artificial viral-like delivery system.
Kakudo T; Chaki S; Futaki S; Nakase I; Akaji K; Kawakami T; Maruyama K; Kamiya H; Harashima H
Biochemistry; 2004 May; 43(19):5618-28. PubMed ID: 15134436
[TBL] [Abstract][Full Text] [Related]
23. Entrapment of small molecules and nucleic acid-based drugs in liposomes.
Fenske DB; Cullis PR
Methods Enzymol; 2005; 391():7-40. PubMed ID: 15721372
[TBL] [Abstract][Full Text] [Related]
24. Novel histidine-conjugated galactosylated cationic liposomes for efficient hepatocyte-selective gene transfer in human hepatoma HepG2 cells.
Shigeta K; Kawakami S; Higuchi Y; Okuda T; Yagi H; Yamashita F; Hashida M
J Control Release; 2007 Apr; 118(2):262-70. PubMed ID: 17267065
[TBL] [Abstract][Full Text] [Related]
25. Antisense oligonucleotides of hepatoma-derived growth factor (HDGF) suppress the proliferation of hepatoma cells.
Kishima Y; Yoshida K; Enomoto H; Yamamoto M; Kuroda T; Okuda Y; Uyama H; Nakamura H
Hepatogastroenterology; 2002; 49(48):1639-44. PubMed ID: 12397753
[TBL] [Abstract][Full Text] [Related]
26. [Construction of an expression vector with a bicistron of green fluorescent protein and HCV 5'NCR controlled luciferase gene and its expression in hepatocytes].
Liu SP; Tan DM; Hou ZH
Hunan Yi Ke Da Xue Xue Bao; 2003 Feb; 28(1):20-2. PubMed ID: 12934387
[TBL] [Abstract][Full Text] [Related]
27. pH-sensitive liposomes: mechanism of triggered release to drug and gene delivery prospects.
Venugopalan P; Jain S; Sankar S; Singh P; Rawat A; Vyas SP
Pharmazie; 2002 Oct; 57(10):659-71. PubMed ID: 12426945
[TBL] [Abstract][Full Text] [Related]
28. Targeted delivery of antisense oligodeoxynucleotide and small interference RNA into lung cancer cells.
Li SD; Huang L
Mol Pharm; 2006; 3(5):579-88. PubMed ID: 17009857
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of tumor necrosis factor alpha secretion and prevention of liver injury in ethanol-fed rats by antisense oligonucleotides.
Ponnappa BC; Israel Y; Aini M; Zhou F; Russ R; Cao QN; Hu Y; Rubin R
Biochem Pharmacol; 2005 Feb; 69(4):569-77. PubMed ID: 15670576
[TBL] [Abstract][Full Text] [Related]
30. Liver target delivery of small interfering RNA to the HCV gene by lactosylated cationic liposome.
Watanabe T; Umehara T; Yasui F; Nakagawa S; Yano J; Ohgi T; Sonoke S; Satoh K; Inoue K; Yoshiba M; Kohara M
J Hepatol; 2007 Dec; 47(6):744-50. PubMed ID: 17822798
[TBL] [Abstract][Full Text] [Related]
31. Epstein-Barr virus-based vector improves the tumor cell killing effect of pituitary tumor in HVJ-liposome-mediated transcriptional targeting suicide gene therapy.
Izumo T; Ohtsuru A; Tokunaga Y; Namba H; Kaneda Y; Nagata I; Yamashita S
Int J Oncol; 2007 Aug; 31(2):379-87. PubMed ID: 17611695
[TBL] [Abstract][Full Text] [Related]
32. [Establishment and the significance of a cell model of secreted alkaline phosphatase co-controlled by HCV 5'NCR and NS3 serine protease].
Liu SP; Tan DM; Yang YF; Hou ZH
Zhonghua Gan Zang Bing Za Zhi; 2004 Sep; 12(9):552-3. PubMed ID: 15387910
[TBL] [Abstract][Full Text] [Related]
33. [Property of liposomal fusion induced by acid-sensitive polymer].
Wang RT; Chen T; Wang Z; Hui MQ; Fu JG
Yao Xue Xue Bao; 2008 Sep; 43(9):951-5. PubMed ID: 19048789
[TBL] [Abstract][Full Text] [Related]
34. Targeted delivery of oncogene-selective antisense oligonucleotides in neuroectodermal tumors: therapeutic implications.
Pastorino F; Brignole C; Marimpietri D; Di Paolo D; Zancolli M; Pagnan G; Ponzoni M
Ann N Y Acad Sci; 2004 Dec; 1028():90-103. PubMed ID: 15650235
[TBL] [Abstract][Full Text] [Related]
35. Antisense inhibitory effect: a comparison between 3'-partial and full phosphorothioate antisense oligonucleotides.
Galderisi U; Di Bernardo G; Melone MA; Galano G; Cascino A; Giordano A; Cipollaro M
J Cell Biochem; 1999 Jul; 74(1):31-7. PubMed ID: 10381259
[TBL] [Abstract][Full Text] [Related]
36. [Optimal effects of liposome on antisense oligodeoxynucleotides uptake by mouse breast cancer TM40D cells and the effects of antisense oligodeoxynucleotides targeting c-erbB-2 on cell proliferation and apoptosis].
Liu XA; Fan P; Wu ZY
Zhonghua Wai Ke Za Zhi; 2004 Jul; 42(13):802-5. PubMed ID: 15363300
[TBL] [Abstract][Full Text] [Related]
37. A potent and specific morpholino antisense inhibitor of hepatitis C translation in mice.
McCaffrey AP; Meuse L; Karimi M; Contag CH; Kay MA
Hepatology; 2003 Aug; 38(2):503-8. PubMed ID: 12883495
[TBL] [Abstract][Full Text] [Related]
38. [Effects of STAT3 antisense oligonucleotide on proliferation and apoptosis of non-small cell lung cancer cell line A549].
Zhu BR; Cai JM; Tang GS; Li BL; Gao F; Cui JG; Liu HC
Ai Zheng; 2007 Aug; 26(8):820-7. PubMed ID: 17697540
[TBL] [Abstract][Full Text] [Related]
39. Conjugation of an antisense oligodeoxynucleotide to ribonuclease h results in sequence-specific cleavage and intracellular inhibition of HCV gene expression.
Fukuma T; Walton CM; Wu CH; Wu GY
Bioconjug Chem; 2003; 14(2):295-301. PubMed ID: 12643739
[TBL] [Abstract][Full Text] [Related]
40. Effect of transferrin as a ligand of pH-sensitive fusogenic liposome-lipoplex hybrid complexes.
Sakaguchi N; Kojima C; Harada A; Koiwai K; Emi N; Kono K
Bioconjug Chem; 2008 Aug; 19(8):1588-95. PubMed ID: 18627196
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
